NIPT/NIPS
White Paper | ACOG – Screening for Chromosomal Abnormalities
Home » NIPT/NIPS » Page 2 Screening for Fetal Chromosomal Abnormalities Prenatal testing for chromosomal abnormalities is designed to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. A wide variety of prenatal screening and diagnostic tests are available; each offers varying levels of information and performance, and
White Paper | ACOG – Screening for Chromosomal Abnormalities Read More »
White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS)
Home » NIPT/NIPS » Page 2 Considerations When Ordering Non-invasive Prenatal Screening (NIPS) NIPS generally relies on blood testing from the mother to reveal information from circulating cell-free DNA (cfDNA) from the placenta, which can be identified in the maternal plasma from five weeks after conception. CfDNA is released into the blood stream as small
White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS) Read More »
White Paper | Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results
Home » NIPT/NIPS » Page 2 Whole-Genome Sequencing Provides the Most Informative Noninvasive Prenatal Testing Results A comparative analysis of commercially available methods for noninvasive prenatal tests. Download PDF
SignatureDx – What We Do
Home » NIPT/NIPS » Page 2 SignatureDx Resources – What We Do One Pager Download PDF